Next Article in Journal
Ecology of West Nile Virus in North America
Next Article in Special Issue
Pseudo-Mannosylated DC-SIGN Ligands as Potential Adjuvants for HIV Vaccines
Previous Article in Journal
Retroviral Infections in Sheep and Goats: Small Ruminant Lentiviruses and Host Interaction
Previous Article in Special Issue
Is a Pacific Coexistence Between Virus and Host the Unexploited Path That May Lead to an HIV Functional Cure?
Article Menu

Export Article

Open AccessReview
Viruses 2013, 5(9), 2062-2078; doi:10.3390/v5092062

Recombinant Salmonella enterica Serovar Typhimurium as a Vaccine Vector for HIV-1 Gag

Department of Medical Microbiology, University of Zimbabwe, Avondale A178, Harare, Zimbabwe
Division of Medical Virology, University of Cape Town, Observatory 7925, Cape Town, South Africa 
Received: 2 June 2013 / Revised: 5 August 2013 / Accepted: 22 August 2013 / Published: 28 August 2013
(This article belongs to the Special Issue AIDS Vaccine 2014)
View Full-Text   |   Download PDF [213 KB, uploaded 12 May 2015]


The HIV/AIDS epidemic remains a global health problem, especially in Sub-Saharan Africa. An effective HIV-1 vaccine is therefore badly required to mitigate this ever-expanding problem. Since HIV-1 infects its host through the mucosal surface, a vaccine for the virus needs to trigger mucosal as well as systemic immune responses. Oral, attenuated recombinant Salmonella vaccines offer this potential of delivering HIV-1 antigens to both the mucosal and systemic compartments of the immune system. So far, a number of pre-clinical studies have been performed, in which HIV-1 Gag, a highly conserved viral antigen possessing both T- and B-cell epitopes, was successfully delivered by recombinant Salmonella vaccines and, in most cases, induced HIV-specific immune responses. In this review, the potential use of Salmonella enterica serovar Typhimurium as a live vaccine vector for HIV-1 Gag is explored. View Full-Text
Keywords: Salmonella; vaccine; vector; HIV-1 Gag; immune response Salmonella; vaccine; vector; HIV-1 Gag; immune response
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Chin'ombe, N. Recombinant Salmonella enterica Serovar Typhimurium as a Vaccine Vector for HIV-1 Gag. Viruses 2013, 5, 2062-2078.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top